Influenza A(H1N1)pdm09 Virus with Reduced Susceptibility to Baloxavir, Japan, 2024
Emerging Infectious Diseases · 2025-05 · 31 (5)
DOI: 10.3201/eid3105.241123 ↗Kurz gefasst
Fallbericht in der Zeitschrift Emerging Infectious Diseases, 2025-05. Verfasst von Emi Takashita und 17 weiteren Autor:innen. Hauptthemen laut MEDLINE: Antiviral Agents, Dibenzothiepins, Drug Resistance, Viral, Oxazines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Takashita, E., Morita, H., Nagata, S., Fujisaki, S., Miura, H., Ikeda, T., Komabayashi, K., Sasaki, M., Matoba, Y., Takahashi, T., Ogawa, N., Mizuta, K., Ito, S., Kishida, N., Nakamura, K., Shirakura, M., Watanabe, S., & Hasegawa, H. (2025). Influenza A(H1N1)pdm09 Virus with Reduced Susceptibility to Baloxavir, Japan, 2024. Emerging Infectious Diseases, 31(5). https://doi.org/10.3201/eid3105.241123
Vancouver
Takashita E, Morita H, Nagata S, Fujisaki S, Miura H, Ikeda T, et al. Influenza A(H1N1)pdm09 Virus with Reduced Susceptibility to Baloxavir, Japan, 2024. Emerging Infectious Diseases. 2025;31(5). doi:10.3201/eid3105.241123
BibTeX
@article{Takashita2025,
author = {Takashita, Emi and Morita, Hiroko and Nagata, Shiho and Fujisaki, Seiichiro and Miura, Hideka and Ikeda, Tatsuya and Komabayashi, Kenichi and Sasaki, Mika and Matoba, Yohei and Takahashi, Tomoko and Ogawa, Naomi and Mizuta, Katsumi and Ito, Sueshi and Kishida, Noriko and Nakamura, Kazuya and Shirakura, Masayuki and Watanabe, Shinji and Hasegawa, Hideki},
title = {Influenza A(H1N1)pdm09 Virus with Reduced Susceptibility to Baloxavir, Japan, 2024},
journal = {Emerging Infectious Diseases},
year = {2025},
volume = {31},
number = {5},
doi = {10.3201/eid3105.241123}
}
EUVIMED